Phase
Condition
Amyloidosis
Treatment
N/AClinical Study ID
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Case Group
Inclusion Criteria:
Patients diagnosed with "Systemic Light Chain Amyloidosis";
No other severe systemic underlying diseases that affect the examination;
Subjects voluntarily participate in this study, sign the informed consent form;
Age between 18-80 years old, no gender restrictions.
Exclusion
Exclusion Criteria:
Patients with eye diseases of clear causes such as ocular surface malignant tumors,corneal perforation, severe eye trauma, etc.;
Patients with nystagmus;
Severe ocular scar diseases; conjunctival scars with fornix shortening;
Current signs of infection, including fever and undergoing antibiotic treatment;
Mental abnormalities;
Pregnant or breastfeeding women, or women planning to become pregnant within 2years;
NYHA Class IV: Heart disease patients cannot engage in any physical activity, withheart failure symptoms even at rest, and worsening with physical activity;
NT-proBNP > 8,500 ng/L.
Control Group
Inclusion Criteria:
Stable general condition, not patients with "Systemic Light Chain Amyloidosis";
No other severe systemic underlying diseases that affect the examination;
Subjects voluntarily participate in this study, sign the informed consent form;
Age between 18-80 years old, no gender restrictions.
Exclusion Criteria:
Patients with eye diseases of clear causes such as ocular surface malignant tumors,corneal perforation, severe eye trauma, etc.;
Patients with nystagmus;
Severe ocular scar diseases; conjunctival scars with fornix shortening;
Current signs of infection, including fever and undergoing antibiotic treatment;
Mental abnormalities;
Pregnant or breastfeeding women, or women planning to become pregnant within 2years.
Study Design
Connect with a study center
Zhongshan Opthalmic Center
Guangzhou, Guangdong
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.